Evidence map›Paper›PMID 27671365›Full record

ArticleTropical medicine & international health : TM & IH2016

Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint.

Raffaella Ravinetto, Anja De Weggheleire, Thomas P C Dorlo, Sven Francque, An Sokkab, Corinne Pouget, Bruno Meessen, Patricia Tabernero, Paul N Newton, Lut Lynen

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raffaella RavinettoClinical Sciences Department, Institute of Tropical Medicine, Antwerp, Belgium.
Anja De WeggheleireClinical Sciences Department, Institute of Tropical Medicine, Antwerp, Belgium.
Thomas P C DorloDepartment Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Sven FrancqueUniversity of Antwerp, Antwerp, Belgium.
An SokkabSihanouk Hospital Centre of Hope, Phnom Penh, Cambodia.
Corinne PougetQUAMED, Institute of Tropical Medicine, Antwerp, Belgium.
Bruno MeessenPublic Health Department, Institute of Tropical Medicine, Antwerp, Belgium.
Patricia TaberneroINSERM U 1058, Montpellier, France.
Paul N NewtonLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.
Lut LynenClinical Sciences Department, Institute of Tropical Medicine, Antwerp, Belgium.

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

2-NaphthylamineAnilidesAntiviral AgentsBenzimidazolesCarbamatesCyclopropanesDrug IndustryDrug Therapy, CombinationFees, PharmaceuticalFluorenesHealth Services AccessibilityHepatitis C, ChronicHumansImidazolesLactams, MacrocyclicMacrocyclic Compounds2-NaphthylamineAnilidesAntiviral AgentsBenzimidazolesCarbamatesCyclopropanesdaclatasvirdasabuvirFluorenesImidazolesLactams, Macrocyclicledipasvir, sofosbuvir drug combinationMacrocyclic CompoundsombitasvirparitaprevirProlinePyrrolidinesRitonavirSimeprevirSofosbuvirSulfonamidesUracilUridine MonophosphateValineaccess to medicinescounterfeit medicinesessential medicineshepatitis Cquality of medicinessubstandard medicines

Identifiers

PMID27671365
PMCPMC5244681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.